Australia - English - Department of Health (Therapeutic Goods Administration)

besins healthcare australia pty ltd - estradiol hemihydrate, quantity: 0.06 % w/w (equivalent: estradiol, qty 0.06 % w/w) - gel - excipient ingredients: carbomer 980; trolamine; ethanol; purified water - - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women.,- prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis. (see also section 4.4 special warnings and precautions for use),the experience treating women older than 65 years is limited. the lowest effective dose should be used for the shortest duration (see sections 4.2 dose and method of administration and 4.4 special warnings and precautions for use).

Ireland - English - HPRA (Health Products Regulatory Authority)

merck serono limited - estradiol hemihydrate - transdermal patch - 1.5 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - estradiol hemihydrate, quantity: 2.06 mg (equivalent: estradiol, qty 2 mg) - tablet, film coated - excipient ingredients: maize starch; hypromellose; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - symptomatic treatment of oestrogen deficiency due to natural or surgical menopause in hysterectomised post menopausal women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration should be used with the goal being short term use. in women with an intact uteri, use of opposed therapy must be considered.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - estradiol hemihydrate, quantity: 2 mg - drug delivery system, vaginal - excipient ingredients: polysilicone-11; barium sulfate; steareth-2; simethicone; sorbic acid - treatment for atrophic vaginitis (due to estrogen deficiency) in post-menopausal women

Malta - English - Medicines Authority

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - estradiol hemihydrate - vaginal tablet - estradiol hemihydrate 10 µg - sex hormones and modulators of the genital system

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - estradiol hemihydrate - nasal spray solution - 150 microgram

Israel - English - Ministry of Health

j-c health care ltd - estradiol as hemihydrate; estradiol as hemihydrate; norethisterone acetate - patches - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg; estradiol as hemihydrate 3.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

syarikat wellchem sdn. bhd. - estradiol hemihydrate (estradiol) -

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 0.5 mg - estradiol tablets usp are indicated in the: - treatment of moderate to severe vasomotor symptoms associated with the menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure. - treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. - treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). - prevention of osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate. (see clinical pharmacology , clinical studies .) the mainstays for decreasing the risk of postmenop

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 1 mg - estradiol tablets usp are indicated in the: estrogens should not be used in individuals with any of the following conditions: